ACCURAY WKN: A0MKWM ISIN: US0043971052 Kürzel: XEJ Forum: Aktien Thema: Hauptdiskussion
1,775 EUR
+0,28 %+0,005
23. Dec, 14:12:31 Uhr,
L&S Exchange
Kommentare 259
Summer.76,
27.04.2022 22:08 Uhr
0
Accuray Reports Fiscal 2022 Third Quarter Financial Results
https://www.prnewswire.com/news-releases/accuray-reports-fiscal-2022-third-quarter-financial-results-301533954.html
Summer.76,
21.04.2022 17:02 Uhr
0
https://www.prnewswire.com/news-releases/owner-of-arkansas-derby-winner-named-horse-after-the-life-changing-accuray-cyberknife-radiation-therapy-technology-used-to-treat-his-cancer-301529800.html
Summer.76,
31.03.2022 16:49 Uhr
1
10-Year Data Shows Accuray CyberKnife® System Provides Long-Lasting Relief of the Excruciating Pain Caused by Trigeminal Neuralgia
https://www.biospace.com/article/releases/10-year-data-shows-accuray-cyberknife-system-provides-long-lasting-relief-of-the-excruciating-pain-caused-by-trigeminal-neuralgia/
Summer.76,
08.03.2022 17:24 Uhr
1
CARTI Selects Accuray CyberKnife® S7™ System to Increase Access to Advanced Cancer Care for Patients in Rural Communities Throughout Arkansas
CARTI is First in Arkansas to Treat Patients with World's Only Robotic Radiosurgery System
https://www.prnewswire.com/news-releases/carti-selects-accuray-cyberknife-s7-system-to-increase-access-to-advanced-cancer-care-for-patients-in-rural-communities-throughout-arkansas-301497478.html
Summer.76,
15.02.2022 15:50 Uhr
1
https://www.prnewswire.com/news-releases/largest-hospital-in-queensland-australia-acquires-multiple-accuray-radixact-systems-with-the-clearrt-helical-fan-beam-kvct-imaging-and-synchrony-technologies-301481340.html
Summer.76,
10.02.2022 15:29 Uhr
0
https://www.benzinga.com/node/25532597
Summer.76,
27.01.2022 5:26 Uhr
0
Accuray GAAP EPS of $0.00 in-line, revenue of $116.28M beats by $13.35M
https://seekingalpha.com/news/3792078-accuray-gaap-eps-of-0_00-in-line-revenue-of-116_28m-beats-13_35m
FQ2 GAAP EPS of $0.00 in-line.
Revenue of $116.28M (+19.3% Y/Y) beats by $13.35M.
Gross orders of $85.4 million, an increase of 13 percent compared to the prior year.
Revising guidance 2022: Total revenue is being increased to an expected range of $420.0 million to $430.0 million compared to the prior range of $420.0 million to $427.0 million, representing a year-over-year growth at the midpoint of the range of 7%. Adjusted EBITDA is now expected to range between $15.0 million to $20.0 million compared to the prior range of $33.0 million to $35.0 million.
Summer.76,
27.01.2022 5:26 Uhr
0
Accuray Reports Fiscal 2022 Second Quarter Financial Results
https://finance.yahoo.com/news/accuray-reports-fiscal-2022-second-210500213.html
Summer.76,
15.12.2021 15:47 Uhr
1
https://www.prnewswire.com/news-releases/accuray-cyberknife-robotic-radiosurgery-system-receives-shonin-approval-to-treat-trigeminal-neuralgia-a-chronic-pain-condition-affecting-a-facial-nerve-301445066.html
Accuray CyberKnife® Robotic Radiosurgery System Receives Shonin Approval to Treat Trigeminal Neuralgia, a Chronic Pain Condition Affecting a Facial Nerve
- Trigeminal neuralgia, a persistent neurological disorder, is described by some patients as the most excruciating pain human beings can experience(1)
- The approval expands global patient access to the CyberKnife System, an effective, non-invasive treatment alternative to surgery
Summer.76,
07.12.2021 15:38 Uhr
0
Accuray Granted U.S. Patent #11,191,511 'Method and apparatus for image reconstruction and correction using inter-fractional information'
https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=6478&f=G&l=50&d=PTXT&p=130&S1=20211207&OS=20211207&RS=20211207
Summer.76,
10.11.2021 17:42 Uhr
1
Accuray CyberKnife® Robotic Radiotherapy Platform Expands Range of Neurological Indications That Can Be Effectively Treated With Stereotactic Radiosurgery
https://finance.yahoo.com/news/accuray-cyberknife-robotic-radiotherapy-platform-123000176.html
Summer.76,
09.11.2021 18:53 Uhr
1
Accuray Files For U.S. Patent Titled 'Noise and artifact reduction for image scatter correction'
https://www.benzinga.com/news/21/11/23989501/accuray-files-for-u-s-patent-titled-noise-and-artifact-reduction-for-image-scatter-correction
AnLeRe,
04.11.2021 10:32 Uhr
1
👍 stark!
Summer.76,
03.11.2021 21:11 Uhr
1
Accuray Reports Fiscal 2022 First Quarter Financial Results
https://www.prnewswire.com/news-releases/accuray-reports-fiscal-2022-first-quarter-financial-results-301415674.html
Summer.76,
02.11.2021 19:27 Uhr
0
Accuray US Patent & Trademark Office Abstract for Co.s 'Method and apparatus for scatter estimation in cone-beam computed tomography'
https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=6469&f=G&l=50&d=PTXT&p=130&S1=20211102&OS=20211102&RS=20211102
Summer.76,
30.10.2021 8:03 Uhr
0
Accuray jumps to a six-month high as investor website touts the stock
https://seekingalpha.com/news/3760930-accuray-jumps-to-a-six-month-high-as-investor-website-touts-the-stock
Shares of Accuray Incorporated (ARAY +14.6%) surged in morning hours triggering a trading halt after the investor website Banyan Hill recommended buying the stock in a flash alert.
With the biggest intraday gain since August 2020, Accuray (NASDAQ:ARAY) shares have reached the highest level since April. Over 9.7M shares have changed hands, compared to the 65-day average of ~0.7M.
...
Meistdiskutiert
|
Thema | ||
---|---|---|---|
1 | ATOS Hauptdiskussion | +2,27 % | |
2 | Cherry Hauptdiskussion | +16,09 % | |
3 | CYTOMX THERAPEUTICS INC. Hauptdiskussion | -0,24 % | |
4 | TILRAY INC. CL.2 DL-,0001 Hauptdiskussion | +12,12 % | |
5 | VALNEVA SE Hauptdiskussion | -2,88 % | |
6 | NVIDIA Hauptdiskussion | +1,36 % | |
7 | MicroStrategy | +0,04 % | |
8 | MANZ Hauptdiskussion | +9,20 % | |
9 | VW Hauptdiskussion | -3,96 % | |
10 | Dax Prognose | ±0,00 % | Alle Diskussionen |
Aktien
|
Thema | ||
---|---|---|---|
1 | ATOS Hauptdiskussion | +2,27 % | |
2 | Cherry Hauptdiskussion | +15,12 % | |
3 | CYTOMX THERAPEUTICS INC. Hauptdiskussion | -0,24 % | |
4 | TILRAY INC. CL.2 DL-,0001 Hauptdiskussion | +8,60 % | |
5 | VALNEVA SE Hauptdiskussion | -2,88 % | |
6 | NVIDIA Hauptdiskussion | +1,16 % | |
7 | MicroStrategy | +0,27 % | |
8 | MANZ Hauptdiskussion | +9,20 % | |
9 | VW Hauptdiskussion | -3,98 % | |
10 | Palantir ohne Schnickschnack | +1,52 % | Alle Diskussionen |